论文信息 - Protocol for a multicenter, double-blind, randomized, placebo-controlled phase III trial of the inhaled β2-adrenergic receptor agonist salbutamol for transient tachypnea of the newborn (the REFSAL trial) - 字舞流文

Protocol for a multicenter, double-blind, randomized, placebo-controlled phase III trial of the inhaled β2-adrenergic receptor agonist salbutamol for transient tachypnea of the newborn (the REFSAL trial)

H. Sławska | T. Daboval | R. Bokiniec | M. Borszewska-Kornacka | B. Łoniewska | R. Lauterbach | W. Błaż | T. Szczapa | I. Sadowska-Krawczenko | Dariusz Madajczak | Marzena Michalak-Kloc | Iwona Sadowska-Krawczenko